Categories
Change Password!
Reset Password!
Cetirizine among top performers for nasal symptoms...
New international urticaria guideline advances bio...
A major international update to urticaria care is providing clinicians with more detailed recommendations on disease classification, diagnostic w...
Role of parental literacy in correct moisturizer a...
Management of atopic dermatitis (AD) in children relies not only on medical treatment but also on parental understanding of the disease.
Canadian experts update guidance on allergic rhini...
A newly released Canadian-focused practice parameter is reshaping the clinical approach to allergic rhinitis (AR), emphasizing individualized tre...
Long-term dupilumab shows psychological benefits i...
As per the findings of a Phase IV clinical study, long-term treatment with dupilumab can improve emotional functioning in moderate-to-severe atop...
Bee allergy linked to higher H. pylori infection a...
A new retrospective study suggests a potential link between bee allergy and elevated gastric mucosal inflammation, along with a higher prevalence...
Blood biomarkers linked to fibrotic lung changes i...
A new real-world study delivers compelling insights into hypersensitivity pneumonitis (HP), revealing that simple blood biomarkers—neutroph...
Remibrutinib in CSU: Findings from Phase 3 BISCUIT...
Remibrutinib, a highly selective oral Bruton’s tyrosine kinase (BTK) inhibitor, is emerging as a next-generation therapy for the management...
Topical therapies for atopic dermatitis: A review...
Atopic dermatitis (AD), also referred to as eczema, is a widespread chronic inflammatory skin disease affecting millions worldwide.
Intranasal antihistamines and corticosteroids for...
Allergic rhinitis (AR) significantly affects daily functioning, symptom burden, and overall health-related quality of life.
